Armistice Capital, LLC, 10% Owner at ReShape Lifesciences Inc. (RSLS), bought 3,000 shares at $6.49 ($21K) on 2020-01-29, disclosed to the SEC on 2020-01-31.
Open-market purchase of $21k RSLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.49 | 1,000 | $6K | 30.3% |
| 2 | $7.45 | 2,000 | $15K | 69.7% |
| Total | $7.13 avg | 3,000 | $21K | 100% |
| Filing → |
| AVTX | BUY | 2021-09-17 | $25.1M | — | Filing → |
| CERC | BUY | 2021-08-06 | $409K | — | Filing → |
| EYEG | SELL | 2021-08-03 | $830K | — | Filing → |